- $2.05bn
- $1.53bn
- $6.94m
U.S. STOCKS ON THE MOVE-Blackstone, Thermo Fisher, Mastercard
Immunome drops on $150 mln stock sale
Brief: Immunome Says Prices Public Offering Of 19.4 Mln Shares At $7.75 Per Share
Brief: Immunome Announces Proposed Public Offering Of Common Stock
Immunome drops on stock offering
Brief: Hummingbird Bioscience Licenses Novel Antibodies To Immunome
Brief: Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Immunome Inc Files For Resale Of Up To 1.8 Million Shares By The Selling Stockholder - SEC Filing
Immunome Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Immunome Inc To Pay Zentalis $5 Million Upon Milestone Achievement
Brief: Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
Immunome Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Immunome Appoints Phil Tsai As Chief Technical Officer
Brief: Immunome Announces Promotion of Max Rosett to Chief Financial Officer
U.S. RESEARCH ROUNDUP- Domino's Pizza, HCA Healthcare, HCA Healthcare
Brief: Immunome Files For Shelf Of Up To 2.2 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Immunome Inc Said Filed Prospectus Relates To Proposed Resale From Time To Time By Selling Stockholder Of 2.3 Million Shares, Or Shares, Of Common Stock
Immunome Inc reports results for the quarter ended in December - Earnings Summary